This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simon, J. Articles by Kasson, B. G. Search for Related Content PubMed PubMed Citation Articles by Simon, J. Articles by Kasson, B. G.

(Hypertension. 1995;25:1030-1033.)
© 1995 American Heart Association, Inc.

Articles

Identification of Vasopressin mRNA in Rat Aorta

Jason Simon; Barry G. Kasson

From the Department of Pharmacology and the Cardiovascular Center, The University of Iowa College of Medicine, Iowa City.

Abstract We have reported previously that several blood vessels of the rat and cow contain immunoreactive vasopressin and further suggested that this peptide might be produced locally. To provide additional support for this hypothesis, we conducted the present study to determine whether mRNA for arginine vasopressin is also present in blood vessels. Ribonuclease protection analysis of total RNA isolated from rat hypothalamus and aorta revealed the presence of arginine vasopressin message in both tissues but not in RNA isolated from liver, a tissue devoid of vasopressin. Subsequent comparison of the autoradiographic intensities of the signals in these two tissues indicated that vasopressin message was 100- to 1000-fold lower in aorta. Additional studies showed that RNA isolated from endothelium-denuded vessels contained levels of arginine vasopressin message similar to those in intact vessels, indicating that endothelium was not a major source of this message. These data were substantiated by further studies using a vasopressin radioimmunoassay, which showed that vasopressin peptide levels in intact and endothelium-denuded vessels did not differ. Thus, the present study showed that rat aorta contains arginine vasopressin mRNA as well as the vasopressin peptide and that both the message and the peptide are contained in nonendothelial structures. However, the data do not rule out endothelium as a possible source of vasopressin. These studies add further support to the hypothesis that blood vessels are capable of producing vasopressin.

Key Words: argipressin • aorta • blood vessels • RNA, messenger

This article has been cited by other articles:

				K. K. Henderson and K. L. Byron Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways J Appl Physiol, April 1, 2007; 102(4): 1402 - 1409. [Abstract] [Full Text] [PDF]

				M. Naitoh, J. Risvanis, L. C. Balding, C. I. Johnston, and L. M. Burrell Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V1a and V2 receptor blockade and ACE inhibition Cardiovasc Res, April 1, 2002; 54(1): 51 - 57. [Abstract] [Full Text] [PDF]

				G. Segarra, P. Medina, C. Domenech, J. M. Vila, J. B. Martínez-León, M. Aldasoro, and S. Lluch Role of Vasopressin on Adrenergic Neurotransmission in Human Penile Blood Vessels J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1315 - 1320. [Abstract] [Full Text]

				K. Yamamoto, U. Ikeda, K. Okada, T. Saito, Y. Kawahara, M. Okuda, M. Yokoyama, and K. Shimada Arginine Vasopressin Increases Nitric Oxide Synthesis in Cytokine-Stimulated Rat Cardiac Myocytes Hypertension, November 1, 1997; 30(5): 1112 - 1120. [Abstract] [Full Text]

				K. L. Byron Vasopressin Stimulates Ca2+ Spiking Activity in A7r5 Vascular Smooth Muscle Cells via Activation of Phospholipase A2 Circ. Res., May 1, 1996; 78(5): 813 - 820. [Abstract] [Full Text]

				M. Jankowski, D. Wang, F. Hajjar, S. Mukaddam-Daher, S. M. McCann, and J. Gutkowska Oxytocin and its receptors are synthesized in the rat vasculature PNAS, May 23, 2000; 97(11): 6207 - 6211. [Abstract] [Full Text] [PDF]